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DNA Based Dual-Spring Cross Shaped Nanoactuator
Alexander H. Mo, Preston B. Landon, Ratnesh Lal.
University of California, San Diego, La Jolla, CA, USA.
DNA is an attractive platform for nanotechnology applications because of its
size, specificity, and designability. However constructing DNA-based plat-
forms that can do work is difficult. We have developed a DNA-based cross-
shaped nanoactuator system that cycles between an extended and contracted
confirmation relying on strand displacement reactions. The actuator contains
4 structural strands with two unique DNA ‘‘zipper’’ sequences. Each zipper
sequence employs traditional adenosine-thymine nucleotides as well as non-
traditional inosine-cytidine nucleotides. The I-C bond consists of only 2 hydro-
gen bonds as opposed to the typical 3 hydrogen bonds found in G-C bonds. The
actuator is extended by inserting two ssDNA which are the natural comple-
ments to the zipper sequences. The natural complements have a stronger bind-
ing affinity to one side of the zipper than both zipper strands have to each other,
thus unraveling and allowing the actuator to extend. The two contraction
strands contain sequences which are a natural complement to parts of the open-
ing strand. When they bind to the extension sequences, the zippers are able to
rebind and this contracts the actuator. Proper assembly and function of the de-
vices was confirmed
using fluorescent
DNA gel electropho-
resis, AFM imaging,
and time-lapsed fluo-
rescence.2114-Plat
Creation of a Biological Wire using Cell-Targeted Paramagnetic Beads
Eugenio Cingolani1, Vittoria Ionta1, Alessandro Giacomello2,
Eduardo Marba´n1, Hee Cheol Cho1.
1Cedars Sinai Heart Institute, Los Angeles, CA, USA, 2Univeristy of
La Sapienza, Rome, Italy.
Introduction: Cardiac conduction delays and blocks are associated with re-
entrant arrhythmias. We sought to create a novel approach to treat such disor-
ders by engineering biological wires designed to bridge or bypass zones of slow
conduction.
Methods: Paramagnetic beads (8 mm diameter) were conjugated with an anti-
body specific for g-sarcoglycan, a cardiomyocyte cell-surface antigen.
Freshly-isolated neonatal rat ventricular cardiomyocytes (NRVMs) were ex-
posed to antibody-coated beads. A biological wire (BioWire) was formed by
exposing the bead-NRVM complex to a linear magnetic field. To create a model
of conduction block, NRVMs were plated in monolayers and mechanically in-
terrupted along the middle. Action potential (AP) propagation and AP duration
were measured by optical mapping.
Results: Prior to bridging, the two sides of an interrupted NRVM monolayer
beat independently. In order to re-establish conduction, BioWire was formed
perpendicular to the axis of interruption, by placing a magnet bridging the
two halves underneath the monolayer. Within one day of BioWire implanta-
tion, the two NRVM islands beat synchronously, and APs propagated from
one island to the other via BioWire with a conduction velocity (CV) of
1854 cm/s. Action potential morphology and APD90 were similar in BioWire
(APD90=44355ms) and the adjacent monolayers (APD90=439512ms,
p=ns). BioWire was amenable to further engineering. Cardiosphere-derived
cells (CDCs), which can couple to and exert anti-apoptotic effects on cardio-
myocytes, were mixed with NRVMs and conjugated to the beads via CD105
(%5% CDCs, BioWire-mx) in order to enhance the physical integrity of Bio-
Wire. When paced, BioWire-mx showed faster CV than that of BioWire (1756
vs 1151 cm/s, n=4).
Conclusion: This proof-of-concept study demonstrates that BioWire could re-
establish cardiac conduction between isolated regions of two-dimensional car-
diac tissue. The approach is highly generalizable, offering a novel platform to
engineer biologically-compatible materials for relaying electrical signals.
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Berkeley, CA, USA.Cellular-electrical connections have the potential to combine the specialties of
the technological world with those of the living world. However, cell mem-
branes are natural insulators, inherently creating a barrier between intracellular
electrons and inorganic materials. To overcome this barrier, we have ‘grown’
electrical connections in living cells by engineering the cell to construct
a well-defined electron conduit. The dissimilatory metal-reducing microbe,
Shewanella oneidensis MR-1, inspired our approach: it has the unusual ability
to transport electrons to extracellular minerals via a trans-membrane electron
transport pathway (ETP). We seek to generalize this ability to grow electrical
contacts between microbes and inorganic materials, and thus have genetically
re-engineered a portion of the Shewanella ETP into Escherichia coli (Fig. A).
Native E. coli proteins complete the partial ETP by acting as a direct electron
donor to the functionally expressed Shewanella proteins. These ’electrified’
strains exhibit ~8x and ~4x faster metal reducing efficiency with soluble metals
and insoluble metal oxides, respectively, than wild-type E. coli (Fig. B). These
experiments provide the first steps towards engineering of hybrid living-
non-living systems.
Our next objective
is to measure direct
electrical output
from the ‘electrified’
strains to an elec-
trode (Fig. C).2116-Plat
Sensitive and Selective Nucleic Acid Capture with Shielded Covalent
Probes
Jeffrey R. Vieregg, Hosea Nelson, Brian Stoltz, Niles A. Pierce.
California Institute of Technology, Pasadena, CA, USA.
Understanding how the parts encoded in the genome interact to build and sus-
tain life is one of the key challenges of modern biology, and nucleic acid probes
are at the heart of many of the techniques used to probe these interactions. In
vitro, they are used to identify genotypes and species, detect nucleic acid-
protein interactions, and measure gene expression patterns in time and space.
In vivo, synthetic nucleic acids are used to inhibit expression for research
and therapeutic interventions. In each of these applications, however, the power
of nucleic acid probes is limited by imperfect selectivity (binding of undesired
targets) and incomplete affinity (not all desired targets are bound). These lim-
itations stem from reliance on base pairing to both bind the desired target and
discriminate against off-target sequences. Longer probes bind the designed tar-
get securely but can also pair imperfectly with undesired targets. Shorter probes
or structured probes such as molecular beacons discriminate mismatches effec-
tively, but at the cost of reduced affinity for the desired target.
We have recently developed a new technology, shielded covalent probes, in or-
der to resolve the selectivity/affinity tradeoff. The probes are designed to fold
into hairpins in the absence of target, ensuring selectivity through competition
between probe-probe and probe-target pairing. Once hybridization is complete,
photo-activatable crosslinkers form covalent bonds between the probe and tar-
get that are far stronger than the non-covalent interactions of base pairing. In
vitro assays show that designed targets are covalently bound with nearly quan-
titative yield, and mismatches are efficiently rejected. Furthermore, the bonds
are stable under extremely stringent conditions, enabling removal of uncros-
slinked molecules. The crosslinks can then be reversed to release the isolated
target. We envision a wide array of applications for these probes.
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Developing new small-molecule drugs against protein targets requires screen-
ing large collections of structurally diverse compounds for those with suffi-
ciently high affinity to and inhibition effect on a protein target before further
structural optimization and developmental work. Small-molecule microarrays
(SMM) with a suitable binding assay platform are one of the viable high-
throughput screening options. We demonstrate that by combining an oblique-
incidence reflectivity difference optical scanner with microarrays, we can
screen >10,000 compounds per glass slide for ligands to a protein target with-
out fluorescence labeling. Using such a platform, we recently screened 8,000
small molecule compounds from the National Cancer Institute Developmental
